help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WALTER, R.
Right arrow Articles by SCHOEDON, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WALTER, R.
Right arrow Articles by SCHOEDON, G.

Am. J. Respir. Crit. Care Med., Volume 156, Number 6, December 1997, 2006-2010

Inhalation of the Nitric Oxide Synthase Cofactor Tetrahydrobiopterin in Healthy Volunteers

ROLAND WALTER, NENAD BLAU, ANDREAS SCHAFFNER, MARKUS SCHNEEMANN, RUDOLF SPEICH, RETO STOCKER, BÄRBEL NAUJECK, and GABRIELE SCHOEDON

Departments of Medicine and Surgery, University Hospital; and Division of Clinical Chemistry and Biochemistry, University Children's Hospital, Zürich, Switzerland

Pulmonary endothelial dysfunction is the hallmark of acute lung injury. Impaired pulmonary endothelial nitric oxide (NO) production in this event has been described. Tetrahydrobiopterin (BH4) is an essential cofactor for NO synthase and modulator of its activity. At high local concentrations, BH4 provokes local vasodilation in vivo in healthy individuals. At lower concentrations, BH4 selectively and locally restores disturbed NO-dependent vasodilation in patients with endothelial dysfunction. In this preliminary study, we therefore investigated the feasibility of BH4 inhalation in five healthy human volunteers. Inhalation of buffered, aqueous BH4-dihydrochloride solution was well tolerated; despite the buffer, BH4 stability was completely preserved. Resorption of inhaled BH4 was demonstrated by significantly increased BH4 levels in plasma and urine. Inhaled BH4 did not alter pulmonary function and had no effect on systemic hemodynamic values. Our data demonstrate that inhalation is a novel method for local BH4 administration, offering a basic therapeutic tool for investigation of restoration of impaired NO-dependent vasodilation due to pulmonary endothelial dysfunction.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, N. C. Pomroy, S.-H. Li, D. A. G. Mickle, R.-K. Li, and V. Rao
Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1074 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Hillinger, P. Sandera, G. L. Carboni, U. Stammberger, M. Zalunardo, G. Schoedon, and R. A. Schmid
Survival and graft function in a large animal lung transplant model after 30 h preservation and substitution of the nitric oxide pathway
Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 508 - 513.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. A. Schmid, S. Hillinger, R. Walter, A. Zollinger, U. Stammberger, R. Speich, A. Schaffner, W. Weder, and G. Schoedon
THE NITRIC OXIDE SYNTHASE COFACTOR TETRAHYDROBIOPTERIN REDUCES ALLOGRAFT ISCHEMIA-REPERFUSION INJURY AFTER LUNG TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 726 - 732.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society